SNN (Smith & Nephew plc) Stock Analysis - Insider Trades

Smith & Nephew plc (SNN) is a publicly traded Healthcare sector company. As of May 21, 2026, SNN trades at $31.01 with a market cap of $12.91B and a P/E ratio of 0.00. SNN moved +0.44% today. Year to date, SNN is -6.99%; over the trailing twelve months it is +5.44%. Its 52-week range spans $23.69 to $38.79. Analyst consensus is neutral with an average price target of $32.32. Rallies surfaces SNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading SNN stock inside the company?

Rallies tracks SNN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

SNN Key Metrics

Key financial metrics for SNN
MetricValue
Price$31.01
Market Cap$12.91B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.48%
52-Week High$38.79
52-Week Low$23.69
Volume1.16K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest SNN News

SNN Analyst Consensus

3 analysts cover SNN: 0 strong buy, 0 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $32.32.

Common questions about SNN

Who is trading SNN stock inside the company?
Rallies tracks SNN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for SNN?
Yes. Rallies tracks SNN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SNN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SNN. It does not provide personalized investment advice.
SNN

SNN